GS-9256

• UNSPSC Description:

  GS-9256 is a selective HCV NS3 protease inhibitor. GS-9256 has good pharmacokinetic properties and antiviral activity[1].

• Target Antigen:

  HCV Protease

• Type:

  Reference compound

• Related Pathways:

  Anti-infection;Metabolic Enzyme/Protease

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/gs-9256.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(OC1CCCC1)N[C@H]2CCCCCCC[C@@]3([H])[C@](C3)(P(O)(CC4=C(F)C=CC=C4F)=O)NC([C@@](C[C@@H](OC5=CC(C6=CSC(NC(C)C)=N6)=NC7=C(Cl)C(OC)=CC=C57)C8)([H])N8C2=O)=O

• Molecular Weight:

  957.46

• References & Citations:

  [1]Huiling Yang, et al. Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256. Antivir Ther. 2017;22(5):413-420.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 2

• CAS Number:

  1001094-46-7